<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="/allregs/css/uswds.min.css">
    <link rel="stylesheet" href="/allregs/css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="/allregs/index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="/allregs/index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="/allregs/html/parts/21CFR522.html">Part 522
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 522.533  Deslorelin.
                            </h3>
                            <p class="depth1"><em>(a)</em> Specifications--(1) Each implant contains 2.1 milligrams (mg) deslorelin acetate.</p><p class="depth2"><em>(1)</em> Each implant contains 2.1 milligrams (mg) deslorelin acetate.</p><p class="depth2"><em>(2)</em> Each milliliter (mL) of suspension contains 1.8 mg deslorelin acetate.</p><p class="depth1"><em>(b)</em> Sponsors. See sponsor numbers in Sec. 510.600(c) of this chapter as follows:</p><p class="depth2"><em>(1)</em> No. 051311 for use of product described in paragraph (a)(1) as in paragraph (c)(1) of this section.</p><p class="depth2"><em>(2)</em> No. 051330 for use of product described in paragraph (a)(2) as in paragraph (c)(2) of this section.</p><p class="depth1"><em>(c)</em> Conditions of use--(1) Horses and ponies--(i) Amount. One implant per mare subcutaneously in the neck.</p><p class="depth2"><em>(1)</em> Horses and ponies--(i) Amount. One implant per mare subcutaneously in the neck.</p><p class="depth3"><em>(i)</em> Amount. One implant per mare subcutaneously in the neck.</p><p class="depth3"><em>(ii)</em> Indications for use. For inducing ovulation within 48 hours in estrous mares with an ovarian follicle greater than 30 mL in diameter.</p><p class="depth3"><em>(iii)</em> Limitations. Do not use in horses or ponies intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.</p><p class="depth2"><em>(2)</em> Horses--(i) Amount. Administer 1.8 mg (1 mL) by intramuscular injection in the neck.</p><p class="depth3"><em>(i)</em> Amount. Administer 1.8 mg (1 mL) by intramuscular injection in the neck.</p><p class="depth3"><em>(ii)</em> Indications for use. For inducing ovulation within 48 hours in cyclic estrous mares with an ovarian follicle between 30 and 40 mL in diameter.</p><p class="depth3"><em>(iii)</em> Limitations. Do not use in horses intended for human consumption. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[75 FR 81456, Dec. 28, 2010, as amended at 79 FR 18158, Apr. 1, 2014]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
